SBIAX | VIHAX | SBIAX / VIHAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 9 years | - |
Gain YTD | 4.942 | 5.296 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 126M | 8.38B | 2% |
Annual Yield % from dividends | 4.42 | 4.87 | 91% |
Returns for 1 year | 13.20 | 11.72 | 113% |
Returns for 3 years | 13.19 | 6.35 | 208% |
Returns for 5 years | 18.54 | 17.95 | 103% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GOVT | 22.61 | N/A | +0.02% |
iShares US Treasury Bond ETF | |||
QPFF | 37.35 | -0.06 | -0.17% |
American Century Quality Preferred ETF | |||
APRZ | 35.16 | -0.32 | -0.90% |
TrueShares Structured Outcome April ETF | |||
TSPA | 36.85 | -0.55 | -1.47% |
T. Rowe Price US Equity Research ETF | |||
PJP | 83.76 | -2.05 | -2.39% |
Invesco Pharmaceuticals ETF |